These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 18804493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P, Nuche-Berenguer B, Gutiérrez-Rojas I, Acitores A, Sancho V, Valverde I, González N, Villanueva-Peñacarrillo ML.
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
    Arnés L, González N, Tornero-Esteban P, Sancho V, Acitores A, Valverde I, Delgado E, Villanueva-Peñacarrillo ML.
    Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state.
    Moreno P, Acitores A, Gutiérrez-Rojas I, Nuche-Berenguer B, El Assar M, Rodriguez-Mañas L, Gomis R, Valverde I, Visa M, Malaisse WJ, Novials A, González N, Villanueva-Peñacarrillo ML.
    Peptides; 2011 Oct; 32(10):2077-85. PubMed ID: 21939703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
    Alcántara AI, Morales M, Delgado E, López-Delgado MI, Clemente F, Luque MA, Malaisse WJ, Valverde I, Villanueva-Peñacarrillo ML.
    Arch Biochem Biophys; 1997 May 01; 341(1):1-7. PubMed ID: 9143346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.
    J Mol Endocrinol; 2005 Aug 01; 35(1):27-38. PubMed ID: 16087719
    [Abstract] [Full Text] [Related]

  • 11. Preserved GLP-I effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats.
    Morales M, López-Delgado MI, Alcántara A, Luque MA, Clemente F, Márquez L, Puente J, Viñambres C, Malaisse WJ, Villanueva-Peñacarrillo ML, Valverde I.
    Diabetes; 1997 Aug 01; 46(8):1264-9. PubMed ID: 9231649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH, Chae SY, Son S, Kim TH, Um KA, Youn YS, Lee S, Lee KC.
    J Control Release; 2009 Feb 10; 133(3):172-7. PubMed ID: 18977255
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.
    Dhanesha N, Joharapurkar A, Shah G, Dhote V, Kshirsagar S, Bahekar R, Jain M.
    Pharmacol Rep; 2012 Feb 10; 64(1):140-9. PubMed ID: 22580530
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.